🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Exposure by Assessment: Effects of Daily AMQ-Based EMA of an Intrusive Trauma Memory in PTSD

RecruitingNAAges 18 Years - 70 YearsAllTel Aviv University
NCT07658157 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Intrusive re-experiencing is a hallmark of PTSD. The study applies ecological momentary assessment (EMA) of participants' trauma memories (active group) vs. EMA of a neutral memory (control group) to test whether the active intervention can reduce intrusive symptoms severity and overal PTSD symptom severity in general.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18-70 * Posttraumatic stress disorder * intrusive symptoms. Exclusion Criteria: * Psychotic or bipolar disorder * Heavy use of drugs or alcohol * Prominent personality disorder * Significant risk of harm to self or others * Current trauma-focused treatment * Reporting intrusions as thoughts only rather than as memories
💊

What it tests

  • AMQ-based ecological momentary assessment of an intrusive memory
  • AMQ-based ecological momentary assessment of an emotionally neutral memory
📍

Where

1 site
Tel Aviv University
Tel Aviv, Israel
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy